This study revealed the gastric cancer-associated lncRNA RNU12 is a tumor-suppressor lncRNA that inhibits cancer progression via miR-575/BLID axis, which plays crucial role in gastric cancer progression and suggest that RNU12 is potential GC marker and target for GC therapy. This evidence concerns the gene BLID and cancer.